Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4719-4745

  Modica, Salvatore ^a   Bellafante, Elena ^a   Moschetta, Antonio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Bile; Cholestasis; Cholesterol; Gene expression; Intestine; Lipids; Liver; Nuclear receptors; Review

Indexed keywords

BILE ACID; CELL RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; DNA BINDING PROTEIN; FARNESOID X RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; PREGNANE X RECEPTOR; STEROID RECEPTOR; TRANSCRIPTION FACTOR; XENOBIOTIC AGENT;

HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

BILE ACIDS AND SALTS; DNA-BINDING PROTEINS; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION FACTORS; XENOBIOTICS;

EID: 63849322336     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3563     Document Type: Article

References (217)

1. D. W. Russell: The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137-174(2003) (Pubitemid 36930444)
2. C. N. Falany, M. R. Johnson, S. Barnes & R. B. Diasio: Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. J. Biol. Chem. 269, 19375-19379(1994)
3. D. A. Vessey, M. H. Crissey & D. Zakim: Kinetic studies on the enzymes conjugating bile acids with taurine and glycine in bovine liver. Biochem. J. 163, 181-183(1977) (Pubitemid 8067076)
4. J. Y. Chiang: Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr. Rev. 23, 443-463(2002) (Pubitemid 34925641)
5. M. W. Love & P. A. Dawson: New insights into bile acid transport. Curr. Opin. Lipidol. 9, 225-229(1998) (Pubitemid 28274352)
6. A. F. Hofmann: Bile Acids: The Good, the Bad, and the Ugly. News Physiol Sci. 14, 24-29(1999)
7. S. G. Lo, M. Petruzzelli & A. Moschetta: A translational view on the biliary lipid secretory network. Biochim. Biophys. Acta 1781, 79-96(2008)
8. J. Reichen: The Role of the Sinusoidal Endothelium in Liver Function. News Physiol Sci. 14, 117-121(1999)
9. G. A. Kullak-Ublick, B. Stieger, B. Hagenbuch & P. J. Meier: Hepatic transport of bile salts. Semin. Liver Dis. 20, 273-292(2000)
10. M. V. St-Pierre, G. A. Kullak-Ublick, B. Hagenbuch & P. J. Meier: Transport of bile acids in hepatic and non-hepatic tissues. J. Exp. Biol. 204, 1673-1686(2001) (Pubitemid 34865965)
11. P. J. Meier: Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am. J. Physiol 269, G801-G812 (1995)
12. G. M. Groothuis, M. J. Hardonk, K. P. Keulemans, P. Nieuwenhuis & D. K. Meijer: Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am. J. Physiol 243, G455-G462 (1982) (Pubitemid 13166240)
13. T. Inagaki, A. Moschetta, Y. K. Lee, L. Peng, G. Zhao, M. Downes, R. T. Yu, J. M. Shelton, J. A. Richardson, J. J. Repa, D. J. Mangelsdorf & S. A. Kliewer: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. U. S. A 103, 3920-3925(2006) (Pubitemid 43376656)
14. A. Moschetta, P. Portincasa, L. Debellis, M. Petruzzelli, R. Montelli, G. Calamita, P. Gustavsson & G. Palasciano: Basolateral Ca2+-dependent K+-channels play a key role in Cl-secretion induced by taurodeoxycholate from colon mucosa. Biol. Cell 95, 115-122(2003) (Pubitemid 36758465)
15. A. Moschetta, G. P. van Berge-Henegouwen, P. Portincasa, W. L. Renooij, A. K. Groen & K. J. van Erpecum: Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. J. Hepatol. 34, 492-499(2001) (Pubitemid 32328504)
16. A. Moschetta, G. P. van Berge-Henegouwen, P. Portincasa, G. Palasciano, A. K. Groen & K. J. van Erpecum: Sphingomyelin exhibits greatly enhanced protection compared with egg yolk phosphatidylcholine against detergent bile salts. J. Lipid Res. 41, 916-924(2000) (Pubitemid 30434322)
17. A. Moschetta, P. M. Frederik, P. Portincasa, G. P. van Berge-Henegouwen & K. J. van Erpecum: Incorporation of cholesterol in sphingomyelinphosphatidylcholine vesicles has profound effects on detergent-induced phase transitions. J. Lipid Res. 43, 1046-1053(2002) (Pubitemid 34760875)
18. M. Petruzzelli, A. Moschetta, W. Renooij, M. B. de Smet, G. Palasciano, P. Portincasa & K. J. van Erpecum: Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury. Dig. Dis. Sci. 51, 766-774(2006)
19. A. L. Velardi, A. K. Groen, R. P. Elferink, M. R. vander, G. Palasciano & G. N. Tytgat: Cell typedependent effect of phospholipid and cholesterol on bile salt cytotoxicity. Gastroenterology 101, 457-464(1991)
20. J. J. Smit, A. H. Schinkel, R. P. Oude Elferink, A. K. Groen, E. Wagenaar, D. L. van, C. A. Mol, R. Ottenhoff, N. M. van der Lugt, M. A. van Roon &.: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462(1993) (Pubitemid 23335071)
21. B. Hagenbuch & P. J. Meier: The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 1609, 1-18(2003) (Pubitemid 36044060)
22. L. Li, T. K. Lee, P. J. Meier & N. Ballatori: Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem. 273, 16184-16191(1998) (Pubitemid 28311391)
23. L. M. Satlin, V. Amin & A. W. Wolkoff: Organic anion transporting polypeptide mediates organic anion/HCO3-exchange. J. Biol. Chem. 272, 26340-26345(1997) (Pubitemid 27458848)
24. L. Li, P. J. Meier & N. Ballatori: Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol. Pharmacol. 58, 335-340(2000) (Pubitemid 30497477)
25. B. Hagenbuch & P. J. Meier: Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 447, 653-665(2004) (Pubitemid 38241451)
26. I. Tamai, J. Nezu, H. Uchino, Y. Sai, A. Oku, M. Shimane & A. Tsuji: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 273, 251-260(2000) (Pubitemid 30426895)
27. P. J. Meier & B. Stieger: Bile salt transporters. Annu. Rev. Physiol 64, 635-661(2002) (Pubitemid 34259244)
28. K. Fattinger, V. Cattori, B. Hagenbuch, P. J. Meier & B. Stieger: Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Hepatology 32, 82-86(2000) (Pubitemid 30432369)
29. S. R. Vavricka, M. J. Van, H. R. Ha, P. J. Meier & K. Fattinger: Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 36, 164-172(2002) (Pubitemid 34700774)
30. V. Cattori, U. Eckhardt & B. Hagenbuch: Molecular cloning and functional characterization of two alternatively spliced Ntcp isoforms from mouse liver1. Biochim. Biophys. Acta 1445, 154-159(1999) (Pubitemid 29193217)
31. B. Hagenbuch, B. Stieger, M. Foguet, H. Lubbert & P. J. Meier: Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc. Natl. Acad. Sci. U. S. A 88, 10629-10633(1991) (Pubitemid 21915890)
32. B. Hagenbuch & P. J. Meier: Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J. Clin. Invest 93, 1326-1331(1994) (Pubitemid 24087193)
33. B. Hagenbuch & P. Dawson: The sodium bile salt cotransport family SLC10. Pflugers Arch. 447, 566-570(2004) (Pubitemid 38241441)
34. D. W. Nebert, M. Adesnik, M. J. Coon, R. W. Estabrook, F. J. Gonzalez, F. P. Guengerich, I. C. Gunsalus, E. F. Johnson, B. Kemper, W. Levin &.: The P450 gene superfamily: recommended nomenclature. DNA 6, 1-11(1987) (Pubitemid 17033547)
35. K. Nagata & Y. Yamazoe: Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol. Toxicol. 40, 159-176(2000) (Pubitemid 30340677)
36. C. A. Strott: Steroid sulfotransferases. Endocr. Rev. 17, 670-697(1996) (Pubitemid 26425261)
37. L. J. Chen & I. H. Segel: Purification and characterization of bile salt sulfotransferase from human liver. Arch. Biochem. Biophys. 241, 371-379(1985) (Pubitemid 15023265)
38. A. Radominska, K. A. Comer, P. Zimniak, J. Falany, M. Iscan & C. N. Falany: Human liver steroid sulphotransferase sulphates bile acids. Biochem. J. 272, 597-604(1990)
39. C. S. Song, I. Echchgadda, B. S. Baek, S. C. Ahn, T. Oh, A. K. Roy & B. Chatterjee: Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J. Biol. Chem. 276, 42549-42556(2001)
40. P. I. Mackenzie, I. S. Owens, B. Burchell, K. W. Bock, A. Bairoch, A. Belanger, S. Fournel-Gigleux, M. Green, D. W. Hum, T. Iyanagi, D. Lancet, P. Louisot, J. Magdalou, J. R. Chowdhury, J. K. Ritter, H. Schachter, T. R. Tephly, K. F. Tipton & D. W. Nebert: The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7, 255-269(1997) (Pubitemid 27358064)
41. P. I. Mackenzie, K. W. Bock, B. Burchell, C. Guillemette, S. Ikushiro, T. Iyanagi, J. O. Miners, I. S. Owens & D. W. Nebert: Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics 15, 677-685(2005) (Pubitemid 41345319)
42. P. Mackenzie, J. M. Little & A. Radominska-Pandya: Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochem. Pharmacol. 65, 417-421(2003) (Pubitemid 36084558)
43. S. B. Senafi, D. J. Clarke & B. Burchell: Investigation of the substrate specificity of a cloned expressed human bilirubin UDP- glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J. 303(Pt 1), 233-240(1994) (Pubitemid 24302924)
44. D. J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon & R. M. Evans: The nuclear receptor superfamily: the second decade. Cell 83, 835-839(1995)
45. N. Y. Kalaany & D. J. Mangelsdorf: LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol 68, 159-191(2006)
46. S. A. Kliewer & T. M. Willson: Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J. Lipid Res. 43, 359-364(2002) (Pubitemid 34252265)
47. W. Xie & R. M. Evans: Orphan nuclear receptors: the exotics of xenobiotics. J. Biol. Chem. 276, 37739-37742(2001)
48. B. M. Forman, E. Goode, J. Chen, A. E. Oro, D. J. Bradley, T. Perlmann, D. J. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, R. M. Evans & C. Weinberger: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693(1995)
49. M. Makishima, A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf & B. Shan: Identification of a nuclear receptor for bile acids. Science 284, 1362-1365(1999) (Pubitemid 29289663)
50. D. J. Parks, S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore & J. M. Lehmann: Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368(1999) (Pubitemid 29289664)
51. H. Wang, J. Chen, K. Hollister, L. C. Sowers & B. M. Forman: Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3, 543-553(1999) (Pubitemid 29268438)
52. C. J. Sinal, M. Tohkin, M. Miyata, J. M. Ward, G. Lambert & F. J. Gonzalez: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731-744(2000)
53. T. Kok, C. V. Hulzebos, H. Wolters, R. Havinga, L. B. Agellon, F. Stellaard, B. Shan, M. Schwarz & F. Kuipers: Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J. Biol. Chem. 278, 41930-41937(2003) (Pubitemid 37310455)
54. G. Bertilsson, J. Heidrich, K. Svensson, M. Asman, L. Jendeberg, M. Sydow-Backman, R. Ohlsson, H. Postlind, P. Blomquist & A. Berkenstam: Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U. S. A 95, 12208-12213(1998) (Pubitemid 28483744)
55. B. Blumberg, W. Sabbagh, Jr., H. Juguilon, J. Bolado, Jr., C. M. van Meter, E. S. Ong & R. M. Evans: SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12, 3195-3205(1998) (Pubitemid 28496264)
56. S. A. Kliewer, J. T. Moore, L. Wade, J. L. Staudinger, M. A. Watson, S. A. Jones, D. D. McKee, B. B. Oliver, T. M. Willson, R. H. Zetterstrom, T. Perlmann & J. M. Lehmann: An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82(1998) (Pubitemid 28053299)
57. J. M. Lehmann, D. D. McKee, M. A. Watson, T. M. Willson, J. T. Moore & S. A. Kliewer: The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest 102, 1016-1023(1998) (Pubitemid 28419246)
58. W. Xie, J. L. Barwick, M. Downes, B. Blumberg, C. M. Simon, M. C. Nelson, B. A. Neuschwander-Tetri, E. M. Brunt, P. S. Guzelian & R. M. Evans: Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406, 435-439(2000) (Pubitemid 30625566)
59. W. Xie, A. Radominska-Pandya, Y. Shi, C. M. Simon, M. C. Nelson, E. S. Ong, D. J. Waxman & R. M. Evans: An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U. S. A 98, 3375-3380(2001) (Pubitemid 32220853)
60. M. Baes, T. Gulick, H. S. Choi, M. G. Martinoli, D. Simha & D. D. Moore: A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell Biol. 14, 1544-1552(1994) (Pubitemid 24074550)
61. P. Wei, J. Zhang, M. Egan-Hafley, S. Liang & D. D. Moore: The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920-923(2000)
62. D. Smirlis, R. Muangmoonchai, M. Edwards, I. R. Phillips & E. A. Shephard: Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics. J. Biol. Chem. 276, 12822-12826(2001)
63. P. Wei, J. Zhang, D. H. Dowhan, Y. Han & D. D. Moore: Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics. J. 2, 117-126(2002) (Pubitemid 34982215)
64. W. Xie, J. L. Barwick, C. M. Simon, A. M. Pierce, S. Safe, B. Blumberg, P. S. Guzelian & R. M. Evans: Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14, 3014-3023(2000)
65. J. T. Moore, L. B. Moore, J. M. Maglich & S. A. Kliewer: Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta 1619, 235-238(2003) (Pubitemid 36160601)
66. K. Kobayashi, T. Sueyoshi, K. Inoue, R. Moore & M. Negishi: Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol. Pharmacol. 64, 1069-1075(2003) (Pubitemid 37310739)
67. K. Yoshinari, K. Kobayashi, R. Moore, T. Kawamoto & M. Negishi: Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett. 548, 17-20(2003) (Pubitemid 37281243)
68. K. Solaas, A. Ulvestad, O. Soreide & B. F. Kase: Subcellular organization of bile acid amidation in human liver: a key issue in regulating the biosynthesis of bile salts. J. Lipid Res. 41, 1154-1162(2000) (Pubitemid 30483021)
69. J. O'Byrne, M. C. Hunt, D. K. Rai, M. Saeki & S. E. Alexson: The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine. J. Biol. Chem. 278, 34237-34244(2003) (Pubitemid 37553266)
70. K. Solaas, B. F. Kase, V. Pham, K. Bamberg, M. C. Hunt & S. E. Alexson: Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR alpha activation favors the formation of unconjugated bile acids. J. Lipid Res. 45, 1051-1060(2004) (Pubitemid 38679500)
71. P. C. Pircher, J. L. Kitto, M. L. Petrowski, R. K. Tangirala, E. D. Bischoff, I. G. Schulman & S. K. Westin: Farnesoid X receptor regulates bile acidamino acid conjugation. J. Biol. Chem. 278, 27703-27711(2003) (Pubitemid 36899959)
72. J. Y. Chiang: Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40, 539-551(2004) (Pubitemid 38230860)
73. J. M. Lehmann, S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer & T. M. Willson: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140(1997) (Pubitemid 27066798)
74. D. J. Peet, S. D. Turley, W. Ma, B. A. Janowski, J. M. Lobaccaro, R. E. Hammer & D. J. Mangelsdorf: Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93, 693-704(1998) (Pubitemid 28257577)
75. B. Goodwin, M. A. Watson, H. Kim, J. Miao, J. K. Kemper & S. A. Kliewer: Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol. Endocrinol. 17, 386-394(2003) (Pubitemid 36315633)
76. L. B. Agellon, V. A. Drover, S. K. Cheema, G. F. Gbaguidi & A. Walsh: Dietary cholesterol fails to stimulate the human cholesterol 7alpha-hydroxylase gene (CYP7A1) in transgenic mice. J. Biol. Chem. 277, 20131-20134(2002) (Pubitemid 34967302)
77. J. Y. Chen, B. Levy-Wilson, S. Goodart & A. D. Cooper: Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J. Biol. Chem. 277, 42588-42595(2002) (Pubitemid 35285627)
78. T. A. Kocarek & N. A. Mercer-Haines: Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol. Pharmacol. 62, 1177-1186(2002) (Pubitemid 35222510)
79. S. D. Shenoy, T. A. Spencer, N. A. Mercer-Haines, M. Abdolalipour, W. L. Wurster, M. Runge-Morris & T. A. Kocarek: Induction of CYP3A by 2, 3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes. Mol. Pharmacol. 65, 1302-1312(2004) (Pubitemid 38543501)
80. B. Goodwin, S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, P. R. Maloney, T. M. Willson & S. A. Kliewer: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517-526(2000)
81. T. T. Lu, M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx & D. J. Mangelsdorf: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6, 507-515(2000)
82. Y. K. Lee & D. D. Moore: Liver receptor homolog-1, an emerging metabolic modulator. Front Biosci. 13, 5950-5958(2008)
83. T. Inagaki, M. Choi, A. Moschetta, L. Peng, C. L. Cummins, J. G. McDonald, G. Luo, S. A. Jones, B. Goodwin, J. A. Richardson, R. D. Gerard, J. J. Repa, D. J. Mangelsdorf & S. A. Kliewer: Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2, 217-225(2005)
84. D. Jung, T. Inagaki, R. D. Gerard, P. A. Dawson, S. A. Kliewer, D. J. Mangelsdorf & A. Moschetta: FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J. Lipid Res. 48, 2693-2700(2007) (Pubitemid 350272854)
85. N. A. van Ooteghem, A. Moschetta, J. F. Rehfeld, M. Samsom, K. J. van Erpecum & G. P. Berge-Henegouwen: Intraduodenal conjugated bile salts exert negative feedback control on gall bladder emptying in the fasting state without affecting cholecystokinin release or antroduodenal motility. Gut 50, 669-674(2002) (Pubitemid 34407495)
86. M. Choi, A. Moschetta, A. L. Bookout, L. Peng, M. Umetani, S. R. Holmstrom, K. Suino-Powell, H. E. Xu, J. A. Richardson, R. D. Gerard, D. J. Mangelsdorf & S. A. Kliewer: Identification of a hormonal basis for gallbladder filling. Nat. Med. 12, 1253-1255(2006) (Pubitemid 44706926)
87. P. Portincasa, A. Di Ciaula, H. H. Wang, G. Palasciano, K. J. van Erpecum, A. Moschetta & D. Q. Wang: Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 47, 2112-2126(2008) (Pubitemid 351945576)
88. J. Staudinger, Y. Liu, A. Madan, S. Habeebu & C. D. Klaassen: Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos. 29, 1467-1472(2001) (Pubitemid 33000694)
89. J. L. Staudinger, B. Goodwin, S. A. Jones, D. Hawkins-Brown, K. I. MacKenzie, A. LaTour, Y. Liu, C. D. Klaassen, K. K. Brown, J. Reinhard, T. M. Willson, B. H. Koller & S. A. Kliewer: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U. S. A 98, 3369-3374(2001) (Pubitemid 32220852)
90. M. Zhang & J. Y. Chiang: Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J. Biol. Chem. 276, 41690-41699(2001)
91. I. Kim, S. H. Ahn, T. Inagaki, M. Choi, S. Ito, G. L. Guo, S. A. Kliewer & F. J. Gonzalez: Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 48, 2664-2672(2007) (Pubitemid 350272851)
92. Y. K. Lee, D. R. Schmidt, C. L. Cummins, M. Choi, L. Peng, Y. Zhang, B. Goodwin, R. E. Hammer, D. J. Mangelsdorf & S. A. Kliewer: Liver receptor homolog-1 regulates bile Acid homeostasis but is not essential for feedback regulation of bile Acid synthesis. Mol. Endocrinol. 22, 1345-1356(2008) (Pubitemid 351786995)
93. C. Mataki, B. C. Magnier, S. M. Houten, J. S. Annicotte, C. Argmann, C. Thomas, H. Overmars, W. Kulik, D. Metzger, J. Auwerx & K. Schoonjans: Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol. Cell Biol. 27, 8330-8339(2007) (Pubitemid 350234244)
94. M. Trauner, P. J. Meier & J. L. Boyer: Molecular pathogenesis of cholestasis. N. Engl. J. Med. 339, 1217-1227(1998)
95. V. Keitel, M. Burdelski, U. Warskulat, T. Kuhlkamp, D. Keppler, D. Haussinger & R. Kubitz: Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41, 1160-1172(2005) (Pubitemid 40593925)
96. G. Zollner, P. Fickert, R. Zenz, A. Fuchsbichler, C. Stumptner, L. Kenner, P. Ferenci, R. E. Stauber, G. J. Krejs, H. Denk, K. Zatloukal & M. Trauner: Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33, 633-646(2001) (Pubitemid 32185226)
97. G. Zollner, P. Fickert, D. Silbert, A. Fuchsbichler, H. U. Marschall, K. Zatloukal, H. Denk & M. Trauner: Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J. Hepatol. 38, 717-727(2003) (Pubitemid 36613336)
98. C. Gartung, M. Ananthanarayanan, M. A. Rahman, S. Schuele, S. Nundy, C. J. Soroka, A. Stolz, F. J. Suchy & J. L. Boyer: Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 110, 199-209(1996) (Pubitemid 26025476)
99. A. Geier, C. G. Dietrich, T. Gerloff, J. Haendly, G. A. Kullak-Ublick, B. Stieger, P. J. Meier, S. Matern & C. Gartung: Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 1609, 87-94(2003) (Pubitemid 36044069)
100. D. Jung, B. Hagenbuch, M. Fried, P. J. Meier & G. A. Kullak-Ublick: Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am. J. Physiol Gastrointest. Liver Physiol 286, G752-G761 (2004) (Pubitemid 38506806)
101. L. A. Denson, K. L. Auld, D. S. Schiek, M. H. McClure, D. J. Mangelsdorf & S. J. Karpen: Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J. Biol. Chem. 275, 8835-8843(2000) (Pubitemid 30180239)
102. S. J. Karpen, A. Q. Sun, B. Kudish, B. Hagenbuch, P. J. Meier, M. Ananthanarayanan & F. J. Suchy: Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J. Biol. Chem. 271, 15211-15221(1996) (Pubitemid 26195002)
103. D. Li, T. L. Zimmerman, S. Thevananther, H. Y. Lee, J. M. Kurie & S. J. Karpen: Interleukin-1 betamediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J. Biol. Chem. 277, 31416-31422(2002) (Pubitemid 34968941)
104. L. A. Denson, E. Sturm, W. Echevarria, T. L. Zimmerman, M. Makishima, D. J. Mangelsdorf & S. J. Karpen: The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121, 140-147(2001) (Pubitemid 32591524)
105. L. Wang, Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin & D. D. Moore: Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721-731(2002) (Pubitemid 34650069)
106. G. Zollner, H. U. Marschall, M. Wagner & M. Trauner: Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol. Pharm. 3, 231-251(2006) (Pubitemid 44021431)
107. G. Zollner, M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H. U. Marschall & M. Trauner: Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am. J. Physiol Gastrointest. Liver Physiol 290, G923-G932 (2006)
108. E. Jacquemin, B. Hagenbuch, B. Stieger, A. W. Wolkoff & P. J. Meier: Expression cloning of a rat liver Na (+)-independent organic anion transporter. Proc. Natl. Acad. Sci. U. S. A 91, 133-137(1994) (Pubitemid 24018657)
109. B. Hagenbuch, I. D. Adler & T. E. Schmid: Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. Biochem. J. 345 Pt 1, 115-120(2000) (Pubitemid 30060111)
110. D. Q. Shih, M. Bussen, E. Sehayek, M. Ananthanarayanan, B. L. Shneider, F. J. Suchy, S. Shefer, J. S. Bollileni, F. J. Gonzalez, J. L. Breslow & M. Stoffel: Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27, 375-382(2001) (Pubitemid 32268417)
111. G. P. Hayhurst, Y. H. Lee, G. Lambert, J. M. Ward & F. J. Gonzalez: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell Biol. 21, 1393-1403(2001) (Pubitemid 32114986)
112. P. Fickert, G. Zollner, A. Fuchsbichler, C. Stumptner, C. Pojer, R. Zenz, F. Lammert, B. Stieger, P. J. Meier, K. Zatloukal, H. Denk & M. Trauner: Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121, 170-183(2001) (Pubitemid 32591527)
113. N. Hagenbuch, C. Reichel, B. Stieger, V. Cattori, K. E. Fattinger, L. Landmann, P. J. Meier & G. A. Kullak-Ublick: Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J. Hepatol. 34, 881-887(2001) (Pubitemid 32595188)
114. S. A. Jones, L. B. Moore, J. L. Shenk, G. B. Wisely, G. A. Hamilton, D. D. McKee, N. C. Tomkinson, E. L. LeCluyse, M. H. Lambert, T. M. Willson, S. A. Kliewer & J. T. Moore: The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14, 27-39(2000) (Pubitemid 32260325)
115. L. C. Rausch-Derra, D. P. Hartley, P. J. Meier & C. D. Klaassen: Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2. Hepatology 33, 1469-1478(2001) (Pubitemid 32496984)
116. B. Gao, B. Stieger, B. Noe, J. M. Fritschy & P. J. Meier: Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem. Cytochem. 47, 1255-1264(1999)
117. M. Kakyo, H. Sakagami, T. Nishio, D. Nakai, R. Nakagomi, T. Tokui, T. Naitoh, S. Matsuno, T. Abe & H. Yawo: Immunohistochemical distribution and functional characterization of an organic anion transporting polypeptide 2 (oatp2) FEBS Lett. 445, 343-346(1999) (Pubitemid 29117241)
118. H. P. Buscher, I. Meder, S. MacNelly & W. Gerok: Zonal changes of hepatobiliary taurocholate transport in intrahepatic cholestasis induced by 17 alpha-ethinyl estradiol: a histoautoradiographic study in rats. Hepatology 17, 494-499(1993) (Pubitemid 23072826)
119. J. Lee & J. L. Boyer: Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin. Liver Dis. 20, 373-384(2000)
120. M. Aiso, H. Takikawa & M. Yamanaka: Biliary excretion of bile acids and organic anions in zone 1-and zone 3-injured rats. Liver 20, 38-44(2000) (Pubitemid 30095286)
121. G. A. Kullak-Ublick, M. G. Ismair, B. Stieger, L. Landmann, R. Huber, F. Pizzagalli, K. Fattinger, P. J. Meier & B. Hagenbuch: Organic aniontransporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120, 525-533(2001) (Pubitemid 32147650)
122. D. Jung, B. Hagenbuch, L. Gresh, M. Pontoglio, P. J. Meier & G. A. Kullak-Ublick: Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J. Biol. Chem. 276, 37206-37214(2001)
123. D. Jung & G. A. Kullak-Ublick: Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 37, 622-631(2003) (Pubitemid 36258784)
124. J. Konig, Y. Cui, A. T. Nies & D. Keppler: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem. 275, 23161-23168(2000) (Pubitemid 30646210)
125. Z. Araya & K. Wikvall: 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim. Biophys. Acta 1438, 47-54(1999) (Pubitemid 29238516)
126. K. Bodin, U. Lindbom & U. Diczfalusy: Novel pathways of bile acid metabolism involving CYP3A4. Biochim. Biophys. Acta 1687, 84-93(2005) (Pubitemid 40228988)
127. A. E. van Herwaarden, E. Wagenaar, C. M. van der Kruijssen, R. A. van Waterschoot, J. W. Smit, J. Y. Song, D. van, V. T. O. van, J. W. van der Hoorn, H. Rosing, J. H. Beijnen & A. H. Schinkel: Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J. Clin. Invest 117, 3583-3592(2007) (Pubitemid 350097013)
128. A. Belanger, G. Pelletier, F. Labrie, O. Barbier & S. Chouinard: Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol. Metab 14, 473-479(2003) (Pubitemid 37517349)
129. F. C. Kauffman: Sulfonation in pharmacology and toxicology. Drug Metab Rev. 36, 823-843(2004) (Pubitemid 39453076)
130. M. R. Podesta, G. M. Murphy & R. H. Dowling: Measurement of faecal bile acid sulphates. J. Chromatogr. 182, 293-300(1980) (Pubitemid 10015666)
131. H. Takikawa, H. Otsuka, T. Beppu, Y. Seyama & T. Yamakawa: Serum concentrations of bile acid glucuronides in hepatobiliary diseases. Digestion 27, 189-195(1983) (Pubitemid 14226071)
132. R. M. Weinshilboum, D. M. Otterness, I. A. Aksoy, T. C. Wood, C. Her & R. B. Raftogianis: Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. FASEB J. 11, 3-14(1997) (Pubitemid 27076319)
133. H. Kitada, M. Miyata, T. Nakamura, A. Tozawa, W. Honma, M. Shimada, K. Nagata, C. J. Sinal, G. L. Guo, F. J. Gonzalez & Y. Yamazoe: Protective role of hydroxysteroid sulfotransferase in lithocholic acidinduced liver toxicity. J. Biol. Chem. 278, 17838-17844(2003) (Pubitemid 36799388)
134. U. Leuschner, P. Czygan, M. Liersch, W. Frohling & A. Stiehl:
135. T. Pillot, M. Ouzzine, S. Fournel-Gigleux, C. Lafaurie, A. Radominska, B. Burchell, G. Siest & J. Magdalou: Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J. Biol. Chem. 268, 25636-25642(1993) (Pubitemid 23358174)
136. W. E. Gall, G. Zawada, B. Mojarrabi, T. R. Tephly, M. D. Green, B. L. Coffman, P. I. Mackenzie & A. Radominska-Pandya: Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J. Steroid Biochem. Mol. Biol. 70, 101-108(1999) (Pubitemid 29406026)
137. J. Trottier, M. Verreault, S. Grepper, D. Monte, J. Belanger, J. Kaeding, P. Caron, T. T. Inaba & O. Barbier: Human UDP-glucuronosyltransferase (UGT) 1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44, 1158-1170(2006) (Pubitemid 44748367)
138. H. Gong, M. W. Sinz, Y. Feng, T. Chen, R. Venkataramanan & W. Xie: Animal models of xenobiotic receptors in drug metabolism and diseases. Methods Enzymol. 400, 598-618(2005) (Pubitemid 43052443)
139. C. Gnerre, S. Blattler, M. R. Kaufmann, R. Looser & U. A. Meyer: Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14, 635-645(2004) (Pubitemid 39411263)
140. H. U. Marschall, M. Wagner, K. Bodin, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. Sjovall & M. Trauner: Fxr (-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J. Lipid Res. 47, 582-592(2006) (Pubitemid 43345599)
141. E. G. Schuetz, S. Strom, K. Yasuda, V. Lecureur, M. Assem, C. Brimer, J. Lamba, R. B. Kim, V. Ramachandran, B. J. Komoroski, R. Venkataramanan, H. Cai, C. J. Sinal, F. J. Gonzalez & J. D. Schuetz: Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J. Biol. Chem. 276, 39411-39418(2001) (Pubitemid 37371319)
142. H. Wietholtz, H. U. Marschall, J. Sjovall & S. Matern: Stimulation of bile acid 6 alphahydroxylation by rifampin. J. Hepatol. 24, 713-718(1996) (Pubitemid 26226668)
143. I. Echchgadda, C. S. Song, T. S. Oh, S. H. Cho, O. J. Rivera & B. Chatterjee: Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR) Mech. Ageing Dev. 125, 733-745(2004) (Pubitemid 39482402)
144. D. Gardner-Stephen, J. M. Heydel, A. Goyal, Y. Lu, W. Xie, T. Lindblom, P. Mackenzie & A. Radominska-Pandya: Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos. 32, 340-347(2004) (Pubitemid 38263893)
145. J. Sonoda, W. Xie, J. M. Rosenfeld, J. L. Barwick, P. S. Guzelian & R. M. Evans: Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR) Proc. Natl. Acad. Sci. U. S. A 99, 13801-13806(2002) (Pubitemid 35215461)
146. C. Frank, M. M. Gonzalez, C. Oinonen, T. W. Dunlop & C. Carlberg: Characterization of DNA complexes formed by the nuclear receptor constitutive androstane receptor. J. Biol. Chem. 278, 43299-43310(2003) (Pubitemid 37345951)
147. W. Xie, M. F. Yeuh, A. Radominska-Pandya, S. P. Saini, Y. Negishi, B. S. Bottroff, G. Y. Cabrera, R. H. Tukey & R. M. Evans: Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. U. S. A 100, 4150-4155(2003) (Pubitemid 36418172)
148. I. S. Owens, N. K. Basu & R. Banerjee: UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol. 400, 1-22(2005) (Pubitemid 43052412)
149. H. L. Fang, S. C. Strom, H. Cai, C. N. Falany, T. A. Kocarek & M. Runge-Morris: Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol. Pharmacol. 67, 1257-1267(2005) (Pubitemid 40410426)
150. O. Barbier, I. P. Torra, A. Sirvent, T. Claudel, C. Blanquart, D. Duran-Sandoval, F. Kuipers, V. Kosykh, J. C. Fruchart & B. Staels: FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124, 1926-1940(2003) (Pubitemid 36666787)
151. Y. Lu, J. M. Heydel, X. Li, S. Bratton, T. Lindblom & A. Radominska-Pandya: Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element. Drug Metab Dispos. 33, 937-946(2005) (Pubitemid 41002775)
152. S. P. Saini, J. Sonoda, L. Xu, D. Toma, H. Uppal, Y. Mu, S. Ren, D. D. Moore, R. M. Evans & W. Xie: A novel constitutive androstane receptormediated and CYP3A-independent pathway of bile acid detoxification. Mol. Pharmacol. 65, 292-300(2004) (Pubitemid 38134256)
153. G. L. Guo, G. Lambert, M. Negishi, J. M. Ward, H. B. Brewer, Jr., S. A. Kliewer, F. J. Gonzalez & C. J. Sinal: Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278, 45062-45071(2003) (Pubitemid 37432638)
154. S. Chen, D. Beaton, N. Nguyen, K. Senekeo-Effenberger, E. Brace-Sinnokrak, U. Argikar, R. P. Remmel, J. Trottier, O. Barbier, J. K. Ritter & R. H. Tukey: Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J. Biol. Chem. 280, 37547-37557(2005) (Pubitemid 41642363)
155. P. Zimniak, E. J. Holsztynska, R. Lester, D. J. Waxman & A. Radominska: Detoxification of lithocholic acid. Elucidation of the pathways of oxidative metabolism in rat liver microsomes. J. Lipid Res. 30, 907-918(1989) (Pubitemid 19167313)
156. T. Zhang, P. Haws & Q. Wu: Multiple variable first exons: a mechanism for cell-and tissue-specific gene regulation. Genome Res. 14, 79-89(2004) (Pubitemid 38088528)
157. G. Zollner, P. Fickert, A. Fuchsbichler, D. Silbert, M. Wagner, S. Arbeiter, F. J. Gonzalez, H. U. Marschall, K. Zatloukal, H. Denk & M. Trauner: Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J. Hepatol. 39, 480-488(2003) (Pubitemid 37204645)
158. M. Ananthanarayanan, N. Balasubramanian, M. Makishima, D. J. Mangelsdorf & F. J. Suchy: Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 276, 28857-28865(2001)
159. T. Gerloff, A. Geier, I. Roots, P. J. Meier & C. Gartung: Functional analysis of the rat bile salt export pump gene promoter. Eur. J. Biochem. 269, 3495-3503(2002)
160. J. R. Plass, O. Mol, J. Heegsma, M. Geuken, K. N. Faber, P. L. Jansen & M. Muller: Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35, 589-596(2002) (Pubitemid 34183962)
161. A. Moschetta, A. L. Bookout & D. J. Mangelsdorf: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat. Med. 10, 1352-1358(2004) (Pubitemid 40022717)
162. P. Portincasa, A. Moschetta & G. Palasciano: Cholesterol gallstone disease. Lancet 368, 230-239(2006) (Pubitemid 44037798)
163. H. R. Kast, B. Goodwin, P. T. Tarr, S. A. Jones, A. M. Anisfeld, C. M. Stoltz, P. Tontonoz, S. Kliewer, T. M. Willson & P. A. Edwards: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 277, 2908-2915(2002) (Pubitemid 34953324)
164. P. A. Dawson, M. Hubbert, J. Haywood, A. L. Craddock, N. Zerangue, W. V. Christian & N. Ballatori: The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J. Biol. Chem. 280, 6960-6968(2005) (Pubitemid 40341252)
165. M. G. Donner & D. Keppler: Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34, 351-359(2001) (Pubitemid 32702348)
166. J. Shoda, M. Kano, K. Oda, J. Kamiya, Y. Nimura, H. Suzuki, Y. Sugiyama, H. Miyazaki, T. Todoroki, S. Stengelin, W. Kramer, Y. Matsuzaki & N. Tanaka: The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 96, 3368-3378(2001) (Pubitemid 34016662)
167. M. Wagner, E. Halilbasic, H. U. Marschall, G. Zollner, P. Fickert, C. Langner, K. Zatloukal, H. Denk & M. Trauner: CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42, 420-430(2005) (Pubitemid 41061095)
168. A. Courtois, L. Payen, F. E. Le, G. L. Scheffer, Y. Trinquart, A. Guillouzo & O. Fardel: Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem. Pharmacol. 63, 333-341(2002) (Pubitemid 34158834)
169. J. M. Maher, X. Cheng, A. L. Slitt, M. Z. Dieter & C. D. Klaassen: Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos. 33, 956-962(2005) (Pubitemid 41002777)
170. N. J. Cherrington, D. P. Hartley, N. Li, D. R. Johnson & C. D. Klaassen: Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 300, 97-104(2002) (Pubitemid 34028514)
171. M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, D. D. Moore, P. Borst & J. D. Schuetz: Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279, 22250-22257(2004) (Pubitemid 38679421)
172. H. Lee, Y. Zhang, F. Y. Lee, S. F. Nelson, F. J. Gonzalez & P. A. Edwards: FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J. Lipid Res. 47, 201-214(2006) (Pubitemid 43107463)
173. J. L. Boyer, M. Trauner, A. Mennone, C. J. Soroka, S. Y. Cai, T. Moustafa, G. Zollner, J. Y. Lee & N. Ballatori: Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am. J. Physiol Gastrointest. Liver Physiol 290, G1124-G1130 (2006) (Pubitemid 43788293)
174. W. Xie, H. Uppal, S. P. Saini, Y. Mu, J. M. Little, A. Radominska-Pandya & M. A. Zemaitis: Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discov. Today 9, 442-449(2004) (Pubitemid 38510563)
175. W. Huang, J. Zhang, S. S. Chua, M. Qatanani, Y. Han, R. Granata & D. D. Moore: Induction of bilirubin clearance by the constitutive androstane receptor (CAR) Proc. Natl. Acad. Sci. U. S. A 100, 4156-4161(2003) (Pubitemid 36418173)
176. P. A. Dawson, J. Haywood, A. L. Craddock, M. Wilson, M. Tietjen, K. Kluckman, N. Maeda & J. S. Parks: Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J. Biol. Chem. 278, 33920-33927(2003) (Pubitemid 37553226)
177. P. Oelkers, L. C. Kirby, J. E. Heubi & P. A. Dawson: Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2) J. Clin. Invest 99, 1880-1887(1997) (Pubitemid 27175935)
178. Y. Z. Gong, E. T. Everett, D. A. Schwartz, J. S. Norris & F. A. Wilson: Molecular cloning, tissue distribution, and expression of a 14-kDa bile acidbinding protein from rat ileal cytosol. Proc. Natl. Acad. Sci. U. S. A 91, 4741-4745(1994) (Pubitemid 24177725)
179. G. P. Tochtrop, G. T. De Koster, D. F. Covey & D. P. Cistola: A single hydroxyl group governs ligand site selectivity in human ileal bile acid binding protein. J. Am. Chem. Soc. 126, 11024-11029(2004) (Pubitemid 39180587)
180. O. Toke, J. D. Monsey, G. T. De Koster, G. P. Tochtrop, C. Tang & D. P. Cistola: Determinants of cooperativity and site selectivity in human ileal bile acid binding protein. Biochemistry 45, 727-737(2006) (Pubitemid 43122237)
181. J. Grober, I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono & P. Besnard: Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cisretinoic acid receptor heterodimer. J. Biol. Chem. 274, 29749-29754(1999)
182. A. Rao, J. Haywood, A. L. Craddock, M. G. Belinsky, G. D. Kruh & P. A. Dawson: The organic solute transporter {alpha}-{beta}, Ost{alpha}-Ost{beta}, is essential for intestinal bile acid transport and homeostasis. Proc. Natl. Acad. Sci. U. S. A (2008)
183. J. F. Landrier, J. J. Eloranta, S. R. Vavricka & G. A. Kullak-Ublick: The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and-beta genes. Am. J. Physiol Gastrointest. Liver Physiol 290, G476-G485 (2006)
184. F. Chen, L. Ma, P. A. Dawson, C. J. Sinal, E. Sehayek, F. J. Gonzalez, J. Breslow, M. Ananthanarayanan & B. L. Shneider: Liver receptor homologue-1 mediates species-and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J. Biol. Chem. 278, 19909-19916(2003) (Pubitemid 36799181)
185. E. Neimark, F. Chen, X. Li & B. L. Shneider: Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Hepatology 40, 149-156(2004) (Pubitemid 38877576)
186. N. Ballatori, W. V. Christian, J. Y. Lee, P. A. Dawson, C. J. Soroka, J. L. Boyer, M. S. Madejczyk & N. Li: OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 42, 1270-1279(2005) (Pubitemid 43260029)
187. D. M. Christie, P. A. Dawson, S. Thevananther & B. L. Shneider: Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. Am. J. Physiol 271, G377-G385 (1996)
188. A. L. Craddock, M. W. Love, R. W. Daniel, L. C. Kirby, H. C. Walters, M. H. Wong & P. A. Dawson: Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am. J. Physiol 274, G157-G169 (1998)
189. J. Lee, F. Azzaroli, L. Wang, C. J. Soroka, A. Gigliozzi, K. D. Setchell, W. Kramer & J. L. Boyer: Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121, 1473-1484(2001) (Pubitemid 33140464)
190. G. U. Denk, C. J. Soroka, Y. Takeyama, W. S. Chen, J. D. Schuetz & J. L. Boyer: Multidrug resistanceassociated protein 4 is up-regulated in liver but downregulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40, 585-591(2004) (Pubitemid 38367779)
191. T. P. Schaub, J. Kartenbeck, J. Konig, H. Spring, J. Dorsam, G. Staehler, S. Storkel, W. F. Thon & D. Keppler: Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J. Am. Soc. Nephrol. 10, 1159-1169(1999) (Pubitemid 29246980)
192. R. A. van Aubel, P. H. Smeets, J. G. Peters, R. J. Bindels & F. G. Russel: The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 13, 595-603(2002) (Pubitemid 34183923)
193. R. Raedsch, B. H. Lauterburg & A. F. Hofmann: Altered bile acid metabolism in primary biliary cirrhosis. Dig. Dis. Sci. 26, 394-401(1981) (Pubitemid 11120725)
194. L. N. Bull, M. J. van Eijk, L. Pawlikowska, J. A. De Young, J. A. Juijn, M. Liao, L. W. Klomp, N. Lomri, R. Berger, B. F. Scharschmidt, A. S. Knisely, R. H. Houwen & N. B. Freimer: A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 18, 219-224(1998) (Pubitemid 28117258)
195. S. S. Strautnieks, L. N. Bull, A. S. Knisely, S. A. Kocoshis, N. Dahl, H. Arnell, E. Sokal, K. Dahan, S. Childs, V. Ling, M. S. Tanner, A. F. Kagalwalla, A. Nemeth, J. Pawlowska, A. Baker, G. Mieli-Vergani, N. B. Freimer, R. M. Gardiner & R. J. Thompson: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20, 233-238(1998) (Pubitemid 28507666)
196. J. M. de Vree, E. Jacquemin, E. Sturm, D. Cresteil, P. J. Bosma, J. Aten, J. F. Deleuze, M. Desrochers, M. Burdelski, O. Bernard, R. P. Oude Elferink & M. Hadchouel: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. U. S. A 95, 282-287(1998) (Pubitemid 28103945)
197. Y. Liu, J. Binz, M. J. Numerick, S. Dennis, G. Luo, B. Desai, K. I. MacKenzie, T. A. Mansfield, S. A. Kliewer, B. Goodwin & S. A. Jones: Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis. J. Clin. Invest 112, 1678-1687(2003) (Pubitemid 38063725)
198. S. Fiorucci, C. Clerici, E. Antonelli, S. Orlandi, B. Goodwin, B. M. Sadeghpour, G. Sabatino, G. Russo, D. Castellani, T. M. Willson, M. Pruzanski, R. Pellicciari & A. Morelli: Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 313, 604-612(2005) (Pubitemid 40604160)
199. C. A. Stedman, C. Liddle, S. A. Coulter, J. Sonoda, J. G. Alvarez, D. D. Moore, R. M. Evans & M. Downes: Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl. Acad. Sci. U. S. A 102, 2063-2068(2005) (Pubitemid 40262012)
200. H. A. Cynamon, J. M. Andres & R. P. Iafrate: Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 98, 1013-1016(1990) (Pubitemid 20095855)
201. C. N. Ghent & S. G. Carruthers: Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 94, 488-493(1988) (Pubitemid 18054790)
202. J. L. Boyer: New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. J. Hepatol. 46, 365-371(2007) (Pubitemid 46201718)
203. T. Li & J. Y. Chiang: Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am. J. Physiol Gastrointest. Liver Physiol 288, G74-G84 (2005) (Pubitemid 39665222)
204. J. L. Boyer: Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease? Gastroenterology 129, 735-740(2005) (Pubitemid 41102188)
205. H. U. Marschall, M. Wagner, G. Zollner, P. Fickert, U. Diczfalusy, J. Gumhold, D. Silbert, A. Fuchsbichler, L. Benthin, R. Grundstrom, U. Gustafsson, S. Sahlin, C. Einarsson & M. Trauner: Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129, 476-485(2005) (Pubitemid 41096635)
206. J. R. Bloomer & J. L. Boyer: Phenobarbital effects in cholestatic liver diseases. Ann. Intern. Med. 82, 310-317(1975)
207. J. Zhang, W. Huang, S. S. Chua, P. Wei & D. D. Moore: Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298, 422-424(2002) (Pubitemid 35176352)
208. J. Zhang, W. Huang, M. Qatanani, R. M. Evans & D. D. Moore: The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J. Biol. Chem. 279, 49517-49522(2004) (Pubitemid 39625839)
209. K. K. Wolf, S. G. Wood, J. A. Hunt, B. W. Walton-Strong, K. Yasuda, L. Lan, S. X. Duan, Q. Hao, S. A. Wrighton, E. H. Jeffery, R. M. Evans, J. G. Szakacs, L. L. von Moltke, D. J. Greenblatt, Court MH, E. G. Schuetz, P. R. Sinclair & J. F. Sinclair: Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity. Drug Metab Dispos. 33, 1827-1836(2005) (Pubitemid 41697268)
210. J. Sonoda, L. W. Chong, M. Downes, G. D. Barish, S. Coulter, C. Liddle, C. H. Lee & R. M. Evans: Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc. Natl. Acad. Sci. U. S. A 102, 2198-2203(2005) (Pubitemid 40262035)
211. K. Bodin, U. Andersson, E. Rystedt, E. Ellis, M. Norlin, I. Pikuleva, G. Eggertsen, I. Bjorkhem & U. Diczfalusy: Metabolism of 4 beta- hydroxycholesterol in humans. J. Biol. Chem. 277, 31534-31540(2002)
212. M. S. Denison & J. P. Whitlock, Jr.: Xenobioticinducible transcription of cytochrome P450 genes. J. Biol. Chem. 270, 18175-18178(1995)
213. F. J. Gonzalez: Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci. 13, 346-352(1992)
214. A. Fugh-Berman: Herb-drug interactions. Lancet 355, 134-138(2000) (Pubitemid 30068565)
215. L. B. Moore, B. Goodwin, S. A. Jones, G. B. Wisely, C. J. Serabjit-Singh, T. M. Willson, J. L. Collins & S. A. Kliewer: St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. U. S. A 97, 7500-7502(2000) (Pubitemid 30431492)
216. S. C. Piscitelli, A. H. Burstein, D. Chaitt, R. M. Alfaro & J. Falloon: Indinavir concentrations and St John's wort. Lancet 355, 547-548(2000) (Pubitemid 30088677)
217. L. B. Moore, D. J. Parks, S. A. Jones, R. K. Bledsoe, T. G. Consler, J. B. Stimmel, B. Goodwin, C. Liddle, S. G. Blanchard, T. M. Willson, J. L. Collins & S. A. Kliewer: Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275, 15122-15127(2000) (Pubitemid 30337234)